Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

Published

on

vialase-to-present-at-the-42nd-congress-of-the-european-society-of-cataract-and-refractive-surgeons-(escrs)

ESCRS presentations will feature clinical data on the ViaLase® Laser, which recently received CE Mark approval in the European Union

ALISO VIEJO, Calif., Sept. 3, 2024 /PRNewswire/ — ViaLase, Inc., a clinical stage medical technology company focused on fueling the practice of incision-free interventional glaucoma, today announced that it will present clinical data as well as provide business and technology overviews during the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2024) to be held September 6-10, 2024 in Barcelona, Spain. ViaLase will be exhibiting onsite at distribution partner booth Teleon (booth #D08).

Presentations at ESCRS 2024 will provide insights into the company’s ViaLase® Laser* and 3-year outcomes of the first-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) treatment in patients with glaucoma. ViaLase recently announced that it had received CE (Conformité Européenne) Mark approval in the European Union (EU) for its ViaLase Laser for the treatment of adult patients with primary open-angle glaucoma (POAG). The ViaLase Laser is the first and only femtosecond laser approved for glaucoma, and will soon become available to physicians and patients in Europe.

In addition to presentations at ESCRS, ViaLase will participate in a panel discussion as part of the Ophthalmology Futures European Forum, which takes place on September 5th in Barcelona.

“On the heels of receiving CE Mark approval, we are thrilled to not only share 3-year clinical data demonstrating the ViaLase Laser’s safety and efficacy, but to meet with physicians onsite at ESCRS to discuss and showcase this groundbreaking technology,” said Tibor Juhasz, PhD, Founder and Chief Executive Officer, ViaLase, Inc. “The ViaLase Laser represents a monumental transformation in interventional glaucoma care in its potential to deliver surgery-like results without the need for surgically opening the eye. This addresses a major unmet need for patients who may benefit from a non-pharmacologic, incision-free procedure without compromising their therapeutic goals.”

The presentations are scheduled as follows:

Ophthalmology Futures European Forum

  • Panel Title: Has MIGS put Glaucoma Pharma Innovation to Sleep?
    • Date: Thursday, September 5, 2024
    • Time: 8:00 a.m. – 8:40 a.m. CET
    • Location: The Esferic, Barcelona
    • Presenter: Shawn O’Neil, Chief Commercial Officer, ViaLase

ESCRS iNovation Day

  • Presentation Title: Introducing the First Image-guided Femtosecond Laser Treatment for Glaucoma
    • Date: Friday, September 6, 2024
    • Time: 2:32 p.m.3:29 p.m. CET
    • Location: Fira Gran Via, Barcelona
    • Presenter: Rick Lewis, MD, Chief Medical Officer, ViaLase

ESCRS

  • E-Poster Title: Sustained 36-Month Reduction in Intraocular Pressure in Open-Angle Glaucoma With Femtosecond Laser-Guided High-Precision Trabeculotomy (FLigHT)
    • Date: Saturday, September 7, 2024
    • Time: 5:00 p.m.6:00 p.m. CET
    • Location: Fira de Barcelona, Foyer between Exhibition Halls 6 & 7
    • Presenter: Zoltan Z. Nagy, MD, PhD, FEBO, FACS
  • Booth Talk: Unveiling FS-Laser Assisted Trabeculotomy
    • Date: Saturday, September 7, 2024
    • Time: 9:15am CET
    • Location: Fira de Barcelona, Exhibition Halls, Teleon Surgical Booth D07
    • Presenter: H. Burkhard Dick, MD, PhD

*The ViaLase Laser is not approved for use in the United States.

About ViaLase, Inc.
ViaLase, Inc. is a globally-minded, venture capital-backed, clinical stage medical technology company located in Aliso Viejo, CA.  ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership team that has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients, ViaLase is now bringing that expertise and innovation to glaucoma patients. ViaLase believes in collaborating closely with health care providers, payers, societies, and patients to inform our product development and commercial activities with the goal of bringing this revolutionary treatment to glaucoma patients across the globe. For more information, visit www.ViaLase.com.

MEDIA CONTACT:
Michele Gray
Gray Communications, LLC.
(917) 449-9250
[email protected]

Logo – https://mma.prnewswire.com/media/1909107/ViaLase.jpg 

Advertisement

Cision View original content:https://www.prnewswire.co.uk/news-releases/vialase-to-present-at-the-42nd-congress-of-the-european-society-of-cataract-and-refractive-surgeons-escrs-302236604.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Statement From Universal Music Group N.V.

Published

on

statement-from-universal-music-group-nv.

HILVERSUM, Netherlands, Nov. 9, 2024 /PRNewswire/ — “We have taken note of Bill Ackman’s post in relation to Pershing Square and UMG on X yesterday. Neither UMG nor any of its other board members were involved in the formulation of the views in that post. As disclosed in UMG’s listing prospectus, Pershing has the right to request a listing in the US subject to a Pershing entity selling at least $500 million in UMG shares as part of the listing. Pershing does not have any right to require UMG to become a US domiciled company or delist from Euronext Amsterdam. While the company will endeavor in good faith to comply with its contractual obligations with respect to undertaking the process of a US listing at the request of Pershing, any actions or decisions beyond those necessary to comply (including any decisions to change the domicile of the company) will be based on an analysis taking into account what is value maximizing and in the best interests of all the shareholders of the company.”

Logo – https://mma.prnewswire.com/media/512308/5017049/UMG.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/statement-from-universal-music-group-nv-302300565.html

Continue Reading

Fintech PR

Manulife Investment Management aligns capabilities across regions under the newly created role of Global Emerging Market Equities CIO

Published

on

manulife-investment-management-aligns-capabilities-across-regions-under-the-newly-created-role-of-global-emerging-market-equities-cio

LONDON, Nov. 8, 2024 /PRNewswire/ — Manulife Investment Management today announced enhancement to its equity organization in leveraging expertise across its Asia and Emerging Markets teams to improve investment experience for its clients.  Charlie Dutton, an equity investment leader with substantial experience in Asia, is named to the newly created role of Chief Investment Officer, Global Emerging Market Equities. In this new role, Charlie will oversee and align our Asia ex-Japan and emerging market equity capabilities, ensuring we leverage local resources and insights across the organization.

Manulife Investment Management has operated in emerging markets for more than a century. Today, it has one of the largest equity teams based in Asia with over 90 investment professionals located across 10 markets in the region. By combining local insight with deep investment expertise, Manulife Investment Management will be able to leverage deeper information advantage over other asset managers based outside of Asia. The combined Emerging Market Equities organization manages over US$25 billion in AUM across Asia and emerging markets equity strategies.

“Collaboration and engagement have always been at the heart of our investment culture, and our emerging markets and Asia equity teams have participated in a variety of forums to exchange ideas and insights.  The closer alignment of the Asia equity team with the global Emerging Markets equity organization formalizes the longstanding sharing of ideas and insights between our Asia and our emerging markets equity teams.  We believe this alignment will translate into improved research sharing and investment decision making, and will enhance our ability to create custom-tailored solutions to meet client needs,” said Colin Purdie, Global Chief Investment Officer, Public Markets, Manulife Investment Management.

Charlie will be spending a considerable amount of time in Asia with the extensive investment teams across the region in the coming months. He will continue to be based in London, affording him the opportunity to work and communicate with the investment teams in London and across Asia effectively, ensuring connections between each.

Charlie brings more than 27 years of investment experience to this role, including over 25 years of Asia equity investment experience with seven years in Hong Kong as well as South Africa and London. Prior to joining Manulife Investment Management’s Emerging Markets Equity team earlier this year, Charlie was a fund manager at Ninety One as part of the Global Quality Capability team that managed assets across five strategies.

Before Ninety One, Charlie was a founding partner at Coupland Cardiff, an Asian investment firm, where he spent 10 years managing Asian focused equity funds. Prior to that, he was based in Hong Kong and served as director of Asia-Pacific research at JPMorgan and as a Hong Kong/China consumer analyst at JF Securities. Charlie started his career at HSBC based in Hong Kong as a HK/China Analyst.

“We are confident Charlie’s deep investment experience, including over 25 years investing in Asia equity, makes him ideally suited to take on the role of CIO, Emerging Markets Equities. We look forward to his leadership, combined with the support of our Asia investment teams, in building upon our strong foundation in the region, and leading our Asia business into the future,” said Steve Medina, Chief Investment Officer, Global Equities, Manulife Investment Management.

At the same time, Manulife Investment Management announced that Kathryn Langridge, Senior Managing Director, Senior Portfolio Manager, and Head of Emerging Markets Equity team, has shared her intention to retire effective October 31, 2025, after an impressive investment career spanning over 40 years.  Meanwhile, Ronald Chan, CIO, Asia ex-Japan Equity, is departing Manulife Investment Management.

“The alignment of the Asia and the Emerging Markets equity teams is a testament to the critical role Asia plays in today’s equity markets, and further draws attention to the deep pool of talent in Manulife’s investment organization,” said Charlie Dutton, Chief Investment Officer, Global Emerging Market Equities. “By globalizing and strengthening this capability, Manulife Investment Management is better positioned to deliver for its clients while expanding the pipeline of research and insight the Emerging Markets equity team can deliver for other capabilities at the firm on a global basis.”

About Manulife Wealth & Asset Management

Advertisement

As part of Manulife Financial Corporation, Manulife Wealth & Asset Management provides global investment, financial advice, and retirement plan services to 19 million individuals, institutions, and retirement plan members worldwide. Our mission is to make decisions easier and lives better by empowering people today to invest for a better tomorrow. As a committed partner to our clients and as a responsible steward of investor capital, we offer a heritage of risk management, deep expertise across public and private markets, and comprehensive retirement plan services. We seek to provide better investment and impact outcomes and to help people confidently save and invest for a more secure financial future. Not all offerings are available in all jurisdictions. For additional information, please visit manulifeim.com

Media contacts: Carl Wong, Manulife Investment Management Asia, +852 2510 3180, [email protected]; Elizabeth Bartlett, Head of Wealth & Asset Management Public Relations, North America & Europe, Manulife Investment Management, +1 857 210 2286, [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/manulife-investment-management-aligns-capabilities-across-regions-under-the-newly-created-role-of-global-emerging-market-equities-cio-302300146.html

Continue Reading

Fintech PR

Palm Jebel Ali Project Surges Ahead in 2024: Milestones Achieved in Record Time for Dubai’s Most Anticipated Development

Published

on

palm-jebel-ali-project-surges-ahead-in-2024:-milestones-achieved-in-record-time-for-dubai’s-most-anticipated-development

DUBAI, UAE, Nov. 8, 2024 /PRNewswire/ — Nakheel, a member of Dubai Holding’s pioneering real estate arm Dubai Holding Real Estate, has marked significant progress in the development of Palm Jebel Ali in 2024, with the project progressing at pace to meet 2025 milestones.

The development masterplan was approved by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai in May 2023, who said at the time; “Palm Jebel Ali will further strengthen our urban infrastructure and consolidate the city’s emergence as one of the world’s leading metropolises. This new groundbreaking project reflects our strategic development plan centred on raising the quality of life and happiness of residents.”

The Palm Jebel Ali area received further recognition this year when His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence, and Chairman of The Executive Council of Dubai, approved the master plan for the 6.6 kilometre development of Jebel Ali Beach. The project includes a five-kilometre sandy beach, to be developed by Nakheel, as well as a 1.6-kilometre-long Mangrove Beach, to be developed by Dubai Municipality.

Khalid Al Malik, Chief Executive Officer of Dubai Holding Real Estate, said; “At Nakheel we believe in developing dreams, inspired by the vision of our leaders and the hopes of our people. The rapid progress we are currently witnessing on ground at Palm Jebel Ali is testimony to the grand success of our key partnerships and our joint endeavours to ensure we deliver on our commitments.”

Several key contracts for the project were awarded throughout 2024, including the construction of a new 6-kilometre road, the contracts for the island’s marine works, dredging, land reclamation, beach profiling and sand placement, directly supporting the construction of villas. The first eight fronds of the project are expected to be site-ready for villa infrastructure and civil works by the first quarter of 2025.

Crucially, the contract for the construction of exclusive ultra-luxury villas on the first six fronds of the project has also been awarded and are scheduled for completion by late 2026. Nakheel recently announced their partnership with Dubai Electricity and Water Authority for the development of two substations on Palm Jebel Ali.

Video: Palm Jebel Ali

Photo – https://mma.prnewswire.com/media/2552884/Nakheel_1.jpg
Photo – https://mma.prnewswire.com/media/2552885/Nakheel_2.jpg
Photo – https://mma.prnewswire.com/media/2552886/Nakheel_3.jpg

Palm Jebel Ali three major contracts signing ceremony

 

Groundbreaking ceremony of marine works on Palm Jebel Ali with Jan De Nul Dredging LTD

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/palm-jebel-ali-project-surges-ahead-in-2024-milestones-achieved-in-record-time-for-dubais-most-anticipated-development-302300134.html

Continue Reading

Trending